UniProt ID | VDAC1_HUMAN | |
---|---|---|
UniProt AC | P21796 | |
Protein Name | Voltage-dependent anion-selective channel protein 1 | |
Gene Name | VDAC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 283 | |
Subcellular Localization |
Mitochondrion outer membrane Multi-pass membrane protein . Cell membrane Multi-pass membrane protein . Membrane raft Multi-pass membrane protein . |
|
Protein Description | Forms a channel through the mitochondrial outer membrane and also the plasma membrane. The channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis. It adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV. The open state has a weak anion selectivity whereas the closed state is cation-selective. [PubMed: 11845315] | |
Protein Sequence | MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAVPPTYAD ------CCCCCCHHH | 23.64 | 2559745 | |
6 | Phosphorylation | --MAVPPTYADLGKS --CCCCCCHHHCCHH | 25.85 | 23401153 | |
7 | Phosphorylation | -MAVPPTYADLGKSA -CCCCCCHHHCCHHH | 12.14 | 23401153 | |
12 | Acetylation | PTYADLGKSARDVFT CCHHHCCHHHHHHHH | 48.52 | 25825284 | |
12 | Malonylation | PTYADLGKSARDVFT CCHHHCCHHHHHHHH | 48.52 | 26320211 | |
12 | Ubiquitination | PTYADLGKSARDVFT CCHHHCCHHHHHHHH | 48.52 | - | |
13 | Phosphorylation | TYADLGKSARDVFTK CHHHCCHHHHHHHHC | 27.09 | 25159151 | |
19 | Phosphorylation | KSARDVFTKGYGFGL HHHHHHHHCCCCCEE | 24.33 | 19764811 | |
20 | Malonylation | SARDVFTKGYGFGLI HHHHHHHCCCCCEEE | 38.38 | 26320211 | |
20 | Acetylation | SARDVFTKGYGFGLI HHHHHHHCCCCCEEE | 38.38 | 19608861 | |
20 | Succinylation | SARDVFTKGYGFGLI HHHHHHHCCCCCEEE | 38.38 | - | |
20 | Succinylation | SARDVFTKGYGFGLI HHHHHHHCCCCCEEE | 38.38 | - | |
20 | Ubiquitination | SARDVFTKGYGFGLI HHHHHHHCCCCCEEE | 38.38 | 21890473 | |
22 | Phosphorylation | RDVFTKGYGFGLIKL HHHHHCCCCCEEEEE | 15.73 | 28152594 | |
28 | Acetylation | GYGFGLIKLDLKTKS CCCCEEEEEECCCCC | 40.78 | 23954790 | |
28 | Ubiquitination | GYGFGLIKLDLKTKS CCCCEEEEEECCCCC | 40.78 | 19608861 | |
33 | Phosphorylation | LIKLDLKTKSENGLE EEEEECCCCCCCCCE | 47.29 | 30108239 | |
34 | Ubiquitination | IKLDLKTKSENGLEF EEEECCCCCCCCCEE | 54.94 | 21906983 | |
34 | Acetylation | IKLDLKTKSENGLEF EEEECCCCCCCCCEE | 54.94 | 26051181 | |
35 | Phosphorylation | KLDLKTKSENGLEFT EEECCCCCCCCCEEE | 41.34 | 30108239 | |
42 | Phosphorylation | SENGLEFTSSGSANT CCCCCEEEECCCCCC | 16.77 | 30108239 | |
43 | Phosphorylation | ENGLEFTSSGSANTE CCCCEEEECCCCCCE | 37.71 | 21712546 | |
44 | Phosphorylation | NGLEFTSSGSANTET CCCEEEECCCCCCEE | 33.44 | 26437602 | |
46 | Phosphorylation | LEFTSSGSANTETTK CEEEECCCCCCEEEE | 21.94 | 25159151 | |
53 | Acetylation | SANTETTKVTGSLET CCCCEEEEEEEEEEE | 45.26 | 26051181 | |
53 | Ubiquitination | SANTETTKVTGSLET CCCCEEEEEEEEEEE | 45.26 | 25621951 | |
55 | Phosphorylation | NTETTKVTGSLETKY CCEEEEEEEEEEEEE | 23.70 | 23403867 | |
57 | Phosphorylation | ETTKVTGSLETKYRW EEEEEEEEEEEEEEE | 17.42 | 29255136 | |
60 | Phosphorylation | KVTGSLETKYRWTEY EEEEEEEEEEEEEEE | 38.37 | 23403867 | |
61 | Malonylation | VTGSLETKYRWTEYG EEEEEEEEEEEEEEC | 24.36 | 26320211 | |
61 | Ubiquitination | VTGSLETKYRWTEYG EEEEEEEEEEEEEEC | 24.36 | 19608861 | |
61 | Acetylation | VTGSLETKYRWTEYG EEEEEEEEEEEEEEC | 24.36 | 23954790 | |
62 | Phosphorylation | TGSLETKYRWTEYGL EEEEEEEEEEEEECE | 20.85 | 20090780 | |
65 | Phosphorylation | LETKYRWTEYGLTFT EEEEEEEEEECEEEE | 15.44 | 30108239 | |
67 | Phosphorylation | TKYRWTEYGLTFTEK EEEEEEEECEEEEEE | 15.29 | 21082442 | |
70 | Phosphorylation | RWTEYGLTFTEKWNT EEEEECEEEEEECCC | 24.93 | 28152594 | |
72 | Phosphorylation | TEYGLTFTEKWNTDN EEECEEEEEECCCCC | 31.27 | 28442448 | |
77 | Phosphorylation | TFTEKWNTDNTLGTE EEEEECCCCCCCCCE | 29.52 | 24641631 | |
80 | Phosphorylation | EKWNTDNTLGTEITV EECCCCCCCCCEEEH | 29.40 | 24641631 | |
83 | Phosphorylation | NTDNTLGTEITVEDQ CCCCCCCCEEEHHHH | 27.59 | 24641631 | |
96 | Acetylation | DQLARGLKLTFDSSF HHHHHCCEEEECCCC | 48.59 | 25953088 | |
98 | Phosphorylation | LARGLKLTFDSSFSP HHHCCEEEECCCCCC | 24.65 | 23927012 | |
101 | Phosphorylation | GLKLTFDSSFSPNTG CCEEEECCCCCCCCC | 29.14 | 23927012 | |
102 | Phosphorylation | LKLTFDSSFSPNTGK CEEEECCCCCCCCCC | 31.43 | 22167270 | |
104 | Phosphorylation | LTFDSSFSPNTGKKN EEECCCCCCCCCCCC | 21.13 | 19664994 | |
107 | Phosphorylation | DSSFSPNTGKKNAKI CCCCCCCCCCCCCEE | 54.48 | 29255136 | |
109 | Sumoylation | SFSPNTGKKNAKIKT CCCCCCCCCCCEEEC | 40.59 | - | |
109 | Malonylation | SFSPNTGKKNAKIKT CCCCCCCCCCCEEEC | 40.59 | 26320211 | |
109 | Ubiquitination | SFSPNTGKKNAKIKT CCCCCCCCCCCEEEC | 40.59 | 21890473 | |
109 | Acetylation | SFSPNTGKKNAKIKT CCCCCCCCCCCEEEC | 40.59 | 25953088 | |
110 | Ubiquitination | FSPNTGKKNAKIKTG CCCCCCCCCCEEECC | 64.58 | 25621951 | |
119 | Acetylation | AKIKTGYKREHINLG CEEECCCCHHHEECC | 53.29 | 7627739 | |
127 | Glutathionylation | REHINLGCDMDFDIA HHHEECCCCCCCCCC | 4.40 | 22555962 | |
137 | Phosphorylation | DFDIAGPSIRGALVL CCCCCCCCHHHEEEE | 24.81 | 21082442 | |
161 | Ubiquitination | QMNFETAKSRVTQSN EECHHHHHHHCCCCC | 46.33 | 21906983 | |
162 | Phosphorylation | MNFETAKSRVTQSNF ECHHHHHHHCCCCCE | 29.53 | 23882029 | |
163 | Methylation | NFETAKSRVTQSNFA CHHHHHHHCCCCCEE | 34.49 | 115919797 | |
165 | Phosphorylation | ETAKSRVTQSNFAVG HHHHHHCCCCCEEEE | 25.77 | 20068231 | |
167 | Phosphorylation | AKSRVTQSNFAVGYK HHHHCCCCCEEEEEE | 25.25 | 20068231 | |
173 | Phosphorylation | QSNFAVGYKTDEFQL CCCEEEEEECCEEEE | 12.24 | 20068231 | |
174 | Methylation | SNFAVGYKTDEFQLH CCEEEEEECCEEEEE | 43.50 | 30583575 | |
174 | Acetylation | SNFAVGYKTDEFQLH CCEEEEEECCEEEEE | 43.50 | 26051181 | |
193 | Phosphorylation | DGTEFGGSIYQKVNK CCCCCCHHHHHHHHH | 20.64 | 28152594 | |
195 | Phosphorylation | TEFGGSIYQKVNKKL CCCCHHHHHHHHHHH | 12.18 | 28152594 | |
197 | Acetylation | FGGSIYQKVNKKLET CCHHHHHHHHHHHHH | 30.70 | 23236377 | |
197 | Ubiquitination | FGGSIYQKVNKKLET CCHHHHHHHHHHHHH | 30.70 | 21906983 | |
201 | Acetylation | IYQKVNKKLETAVNL HHHHHHHHHHHHHHH | 46.48 | 26051181 | |
204 | Phosphorylation | KVNKKLETAVNLAWT HHHHHHHHHHHHHHC | 46.47 | 23312004 | |
211 | O-linked_Glycosylation | TAVNLAWTAGNSNTR HHHHHHHCCCCCCCC | 21.05 | 28657654 | |
211 | Phosphorylation | TAVNLAWTAGNSNTR HHHHHHHCCCCCCCC | 21.05 | 26437602 | |
215 | Phosphorylation | LAWTAGNSNTRFGIA HHHCCCCCCCCEEEE | 38.36 | 20833797 | |
217 | Phosphorylation | WTAGNSNTRFGIAAK HCCCCCCCCEEEEEE | 27.48 | 22673903 | |
224 | Ubiquitination | TRFGIAAKYQIDPDA CCEEEEEEEECCCCC | 28.76 | 19608861 | |
224 | Malonylation | TRFGIAAKYQIDPDA CCEEEEEEEECCCCC | 28.76 | 26320211 | |
224 | Acetylation | TRFGIAAKYQIDPDA CCEEEEEEEECCCCC | 28.76 | 23954790 | |
225 | Phosphorylation | RFGIAAKYQIDPDAC CEEEEEEEECCCCCC | 13.13 | 28152594 | |
232 | Glutathionylation | YQIDPDACFSAKVNN EECCCCCCEEEEECC | 3.45 | 22555962 | |
232 | S-nitrosylation | YQIDPDACFSAKVNN EECCCCCCEEEEECC | 3.45 | 2212679 | |
234 | Phosphorylation | IDPDACFSAKVNNSS CCCCCCEEEEECCCC | 27.37 | 21712546 | |
236 | Acetylation | PDACFSAKVNNSSLI CCCCEEEEECCCCCC | 44.27 | 25825284 | |
236 | Malonylation | PDACFSAKVNNSSLI CCCCEEEEECCCCCC | 44.27 | 26320211 | |
240 | Phosphorylation | FSAKVNNSSLIGLGY EEEEECCCCCCEECC | 22.71 | 25159151 | |
241 | Phosphorylation | SAKVNNSSLIGLGYT EEEECCCCCCEECCC | 26.57 | 21712546 | |
247 | Phosphorylation | SSLIGLGYTQTLKPG CCCCEECCCCCCCCC | 10.75 | 28152594 | |
248 | Phosphorylation | SLIGLGYTQTLKPGI CCCEECCCCCCCCCC | 17.18 | 28152594 | |
250 | Phosphorylation | IGLGYTQTLKPGIKL CEECCCCCCCCCCEE | 29.02 | 25849741 | |
252 | Malonylation | LGYTQTLKPGIKLTL ECCCCCCCCCCEEEH | 44.58 | 26320211 | |
252 | Ubiquitination | LGYTQTLKPGIKLTL ECCCCCCCCCCEEEH | 44.58 | 21890473 | |
252 | Acetylation | LGYTQTLKPGIKLTL ECCCCCCCCCCEEEH | 44.58 | 23954790 | |
258 | Phosphorylation | LKPGIKLTLSALLDG CCCCCEEEHHHHHCC | 17.42 | 21712546 | |
260 | Phosphorylation | PGIKLTLSALLDGKN CCCEEEHHHHHCCCC | 16.19 | 21712546 | |
266 | Acetylation | LSALLDGKNVNAGGH HHHHHCCCCCCCCCC | 58.34 | 19608861 | |
266 | Malonylation | LSALLDGKNVNAGGH HHHHHCCCCCCCCCC | 58.34 | 26320211 | |
266 | Ubiquitination | LSALLDGKNVNAGGH HHHHHCCCCCCCCCC | 58.34 | 19608861 | |
274 | Malonylation | NVNAGGHKLGLGLEF CCCCCCCCCCCCCEE | 47.74 | 26320211 | |
274 | Acetylation | NVNAGGHKLGLGLEF CCCCCCCCCCCCCEE | 47.74 | 25953088 | |
274 | Ubiquitination | NVNAGGHKLGLGLEF CCCCCCCCCCCCCEE | 47.74 | 21890473 | |
274 | Sumoylation | NVNAGGHKLGLGLEF CCCCCCCCCCCCCEE | 47.74 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
13 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
107 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
193 | S | Phosphorylation | Kinase | NEK1 | Q96PY6 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VDAC1_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB01375 | Dihydroxyaluminium |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-104, AND MASS SPECTROMETRY. | |
"Identification of human porins. II. Characterization and primarystructure of a 31-lDa porin from human B lymphocytes (Porin 31HL)."; Kayser H., Kratzin H.D., Thinnes F.P., Goetz H., Schmidt W.E.,Eckart K., Hilschmann N.; Biol. Chem. Hoppe-Seyler 370:1265-1278(1989). Cited for: PROTEIN SEQUENCE OF 2-283. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-20; LYS-28; LYS-61; LYS-224AND LYS-266, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-104, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101 AND SER-104, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 AND THR-107, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-67, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASSSPECTROMETRY. |